Xinhuanet Beijing, March 3 (Reporter Peng Jiajing) On February 28, the Shandong Science and Technology Awards Conference was held to commend the scientific and technological personnel who won the 20 10 national and provincial science and technology awards. The research and development of Danhong injection completed by Heze Buchang Pharmaceutical Co., Ltd. won the first prize of Shandong Science and Technology Progress 20 10.
It is understood that Danhong injection is a traditional Chinese medicine injection developed by Buchang Group with investment of several hundred million yuan according to the two medical theories of "treating brain and heart at the same time" and "insufficient blood supply is the root of all diseases" invented by Professor Zhao Buchang, the chairman of the Board of Directors. It is the first patented Chinese patent medicine in China to quickly solve the problems of insufficient blood supply and ischemic infarction in various organs.
A large number of clinical studies show that Danhong injection is widely used in the whole body (brain, heart, lung, liver, kidney and so on). ) organ blood supply deficiency, especially infarct blood supply deficiency (cerebral infarction, myocardial infarction). Combined with Buchang Naoxintong, it can effectively prevent restenosis, reocclusion and diabetic complications after coronary heart disease stent implantation. With the increase of clinical application of Danhong, Buchang Group has further strengthened its clinical research on Danhong injection. At present, a multi-center, large-sample randomized controlled study of Buchang Danhong injection in the treatment of unstable angina pectoris is being carried out nationwide.
Zhao Tao, president of Buchang Group, said that Danhong injection, as the only patented product of traditional Chinese medicine that won the first prize of scientific and technological progress in Shandong Province, is also an affirmation of the excellent safety and remarkable curative effect of Danhong injection, an original pharmaceutical technology and product. In 20 10, Danhong injection also won the first Chinese medicine patent gold medal among the national patent gold medals.
Zhao Tao introduced that at present, there are nearly 50 national new drugs with independent intellectual property rights represented by Naoxintong Capsule, Wenxin Granule and Danhong Injection in Buchang Group, and 90 of them have been authorized to apply for patent products 160, including invention patents 1 9. There are nearly 80 kinds of products under research, such as Zhi Heng Granules and Tangle 'an Granules, covering cardiovascular and cerebrovascular diseases, tumors, gynecology, digestion, skin and other fields.
"More than 90% of Buchang Group's annual sales revenue comes from the exclusive patented varieties of independent innovation." Zhao Tao said that it is the independent scientific and technological innovation that gives Buchang Group the wings to take off. Danhong Injection of Buchang Group won the first prize of Shandong Science and Technology Progress Award, which will encourage the research and innovation of more patented drugs in China. (End)
(Editor: Peng Jiajing)
Please adopt ~